TLIS Insider Trading Activity and SEC Form 4 Filings
TLIS insider trading summary
No open-market insider purchases or sales of Talis Biomedical Corp (TLIS) have been reported on SEC Form 4 in the past 12 months.
Latest TLIS insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 6, 2024 | Braden Michael Leonard | Insider | Buy | $37K (25,000 @ $1.48) |
| Sep 5, 2024 | Braden Michael Leonard | Insider | Buy | $7K (5,100 @ $1.40) |
| Sep 3, 2024 | Braden Michael Leonard | Insider | Buy | $2K (500 @ $4.00) |
| Aug 30, 2024 | Braden Michael Leonard | Insider | Buy | $642 (151 @ $4.25) |
| Aug 28, 2024 | Braden Michael Leonard | Insider | Buy | $5K (1,215 @ $3.96) |
| Aug 26, 2024 | Braden Michael Leonard | Insider | Buy | $51K (13,167 @ $3.90) |
| Nov 18, 2021 | Baker Bros. Advisors LP | Insider | Buy | $218K (50,000 @ $4.37) |
| Nov 18, 2021 | 667, L.P. | Director | Buy | $218K (50,000 @ $4.37) |
| Nov 18, 2021 | Baker Bros. Advisors (GP) LLC | Director | Buy | $218K (50,000 @ $4.37) |
| Nov 18, 2021 | Julian Baker | Director | Buy | $218K (50,000 @ $4.37) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.